Bioresorbable polymer medical devices market seen reaching $2.28 billion by 2030

The bioresorbable polymer medical devices market is projected to grow from $1.64 billion in 2025 to $2.28 billion by 2030, driven by demand for minimally invasive procedures and temporary implants that dissolve after healing. North America led in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Bioresorbable polymer medical devices reduce the need for follow-up surgery because the implants safely dissolve in the body after tissue healing. - The market’s growth signals wider adoption of temporary implants in surgery, especially where patients and providers want less invasive care and fewer hardware-removal procedures.

What happened: - The Business Research Company projected the global bioresorbable polymer medical devices market will rise from $1.64 billion in 2025 to $1.75 billion in 2026. - The company said the market will reach $2.28 billion by 2030, expanding at a 6.9% CAGR. - The report was released as part of The Business Research Company’s 2026 market research on medical devices. - A free sample of the report is available online.

The details: - Bioresorbable polymer medical devices include therapeutic implants such as vascular stents and orthopedic screws. - The devices are made from materials including polylactic acid and polyglycolic acid. - The implants are designed to break down and be absorbed by the body over time. - That design removes the need for surgery to take the implant out after healing. - The historical growth case cited rising use of minimally invasive procedures, demand for temporary implant solutions, wider use of bioresorbable vascular devices, and efforts to reduce secondary surgeries. - The forecast period is supported by interest in patient-specific implants, greater use of resorbable orthopedic fixation devices, and demand for implants with controlled degradation rates. - The report identifies emerging trends in tailored implant designs, better control of polymer degradation, growth in bioresorbable vascular stents, next-generation biodegradable polymers, and increased use of orthopedic fixation devices that naturally resorb. - North America held the largest market share in 2025 because of advanced healthcare infrastructure, strong R&D capabilities, and early adoption of new medical technologies. - Asia-Pacific is expected to be the fastest-growing region as healthcare investment rises, awareness of advanced treatments increases, and patient populations expand. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market outlook reflects a broader shift toward procedures that reduce recovery time and avoid additional operations. - NHS England said in June 2025 that about 70,000 robot-assisted minimally invasive surgeries were completed across the NHS during 2023-24. - NHS England plans to expand those procedures to 500,000 annually by 2035, with an expected 90% of keyhole surgeries using robot assistance. - That trend helps explain why temporary, resorbable implants are gaining traction in surgical care. - The 2026 report edition also adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated technology and trend analysis.

What's next: - The market’s next phase will likely center on better degradation control, more specialized implant designs, and broader use in orthopedics and vascular care. - Growth in Asia-Pacific could narrow the gap with North America if healthcare investment and adoption continue to accelerate. - More information is available in the company’s full report.